Gregor Manukian

706 total citations
13 papers, 545 citations indexed

About

Gregor Manukian is a scholar working on Oncology, Immunology and Otorhinolaryngology. According to data from OpenAlex, Gregor Manukian has authored 13 papers receiving a total of 545 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Immunology and 3 papers in Otorhinolaryngology. Recurrent topics in Gregor Manukian's work include Cancer Immunotherapy and Biomarkers (5 papers), Immunotherapy and Immune Responses (4 papers) and T-cell and B-cell Immunology (4 papers). Gregor Manukian is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Immunotherapy and Immune Responses (4 papers) and T-cell and B-cell Immunology (4 papers). Gregor Manukian collaborates with scholars based in United States and Greece. Gregor Manukian's co-authors include Stephanie Terzulli, Jedd D. Wolchok, Teresa Rasalan, Jianda Yuan, Humilidad F. Gallardo, Hao Li, Geoffrey Y. Ku, Yinyan Xu, Lloyd J. Old and James P. Allison and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Gregor Manukian

13 papers receiving 534 citations

Peers

Gregor Manukian

IMMUN

ONCOL

MB

PRM

RNMI

Sjoerd van der Burg Netherlands

Rebecca C. Obeng United States

Ulf Forssmann Germany

Berbel J.R. Sluijter Netherlands

François Audhuy United States

Rehana Hewavisenti Australia

Abdul Mohammad Pezeshki Iran

Pornpan Youngnak Japan

Szilvia Mosolits Sweden

Rajesh M. Valanparambil United States

Sjoerd van der Burg Netherlands

Gregor Manukian

409 ×1.0

IMMUN

397 ×1.2

ONCOL

123 ×0.8

MB

63 ×1.2

PRM

18 ×0.4

RNMI

Citations per year, relative to Gregor Manukian Gregor Manukian (= 1×) peers Sjoerd van der Burg

Countries citing papers authored by Gregor Manukian

Since Specialization

Citations

This map shows the geographic impact of Gregor Manukian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregor Manukian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregor Manukian more than expected).

Fields of papers citing papers by Gregor Manukian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregor Manukian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregor Manukian. The network helps show where Gregor Manukian may publish in the future.

Co-authorship network of co-authors of Gregor Manukian

This figure shows the co-authorship network connecting the top 25 collaborators of Gregor Manukian. A scholar is included among the top collaborators of Gregor Manukian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregor Manukian. Gregor Manukian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Manukian, Gregor, Jennifer M. Johnson, Rita Axelrod, et al.. (2023). In-Field Toxicity Analysis of a Phase 1 Clinical Trial of Nivolumab and Ipilimumab With Definitive Radiation Therapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck. International Journal of Radiation Oncology*Biology*Physics. 117(1). 181–185. 3 indexed citations

2.

Manukian, Gregor, Tiziana DeAngelis, Anuradha A. Shastri, et al.. (2021). Caloric Restriction Impairs Regulatory T cells Within the Tumor Microenvironment After Radiation and Primes Effector T cells. International Journal of Radiation Oncology*Biology*Physics. 110(5). 1341–1349. 29 indexed citations

3.

Song, Andrew, Gregor Manukian, Amy K. Taylor, Pramila R. Anné, & Nicole L. Simone. (2020). Concerns for Active Breathing Control (ABC) With Breast Cancer in the Era of COVID-19: Maximizing Infection Control While Minimizing Heart Dose. Advances in Radiation Oncology. 5(4). 573–574. 9 indexed citations

4.

Manukian, Gregor, Jennifer M. Johnson, Adam Luginbuhl, et al.. (2020). Nivolumab and Ipilimumab Combined with Definitive Radiation Therapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck: In-field Toxicity Analysis of a Phase I Clinical Trial. International Journal of Radiation Oncology*Biology*Physics. 108(3). S106–S107. 3 indexed citations

5.

Johnson, Jennifer M., Voichita Bar Ad, Gregor Manukian, et al.. (2020). Nivolumab (Nivo) and ipilimumab (Ipi) in combination with radiotherapy (RT) in high-risk patients (pts) with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN).. Journal of Clinical Oncology. 38(15_suppl). 6577–6577. 5 indexed citations

6.

Manukian, Gregor, Voichita Bar‐Ad, Bo Lü, Athanassios Argiris, & Jennifer M. Johnson. (2019). Combining Radiation and Immune Checkpoint Blockade in the Treatment of Head and Neck Squamous Cell Carcinoma. Frontiers in Oncology. 9. 122–122. 55 indexed citations

7.

Manukian, Gregor, et al.. (2019). Caloric Restriction Curtails Tumor Infiltrating Regulatory T Cells and Enhances Effector T Cell Activity after Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 105(1). S164–S164. 1 indexed citations

8.

Manukian, Gregor, et al.. (2013). [Surgical treatment of portal hypertension: the state of art].. PubMed. 30–4. 3 indexed citations

9.

Lin, Yun, Humilidad F. Gallardo, Geoffrey Y. Ku, et al.. (2009). Optimization and validation of a robust human T-cell culture method for monitoring phenotypic and polyfunctional antigen-specific CD4 and CD8 T-cell responses. Cytotherapy. 11(7). 912–922. 29 indexed citations

10.

Yuan, Jianda, Geoffrey Y. Ku, Humilidad F. Gallardo, et al.. (2009). Safety and immunogenicity of a human and mouse gp100 DNA vaccine in a phase I trial of patients with melanoma.. PubMed. 9. 5–5. 62 indexed citations

11.

Lin, Yun, Humilidad F. Gallardo, Geoffrey Y. Ku, et al.. (2009). Optimization and validation of a robust human T-cell culture method for monitoring phenotypic and polyfunctional antigen-specific CD4 and CD8 T-cell responses. Cytotherapy. 1–11. 3 indexed citations

12.

Perales, Miguel‐Angel, Jianda Yuan, Humilidad F. Gallardo, et al.. (2008). Phase I/II Study of GM-CSF DNA as an Adjuvant for a Multipeptide Cancer Vaccine in Patients With Advanced Melanoma. Molecular Therapy. 16(12). 2022–2029. 76 indexed citations

13.

Yuan, Jianda, Sacha Gnjatic, Hao Li, et al.. (2008). CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit. Proceedings of the National Academy of Sciences. 105(51). 20410–20415. 267 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact